- Report
- July 2025
- 350 Pages
Global
From €4402EUR$4,949USD£3,825GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2481EUR$2,789USD£2,155GBP
- Report
- June 2025
- 400 Pages
Global
From €4402EUR$4,949USD£3,825GBP
- Report
- June 2025
- 400 Pages
Global
From €4402EUR$4,949USD£3,825GBP
- Report
- September 2025
- 86 Pages
Global
From €3500EUR$4,215USD£3,147GBP
- Report
- September 2025
- 150 Pages
Global
From €3425EUR$3,850USD£2,975GBP
- Report
- August 2025
- 150 Pages
Global
From €2535EUR$2,850USD£2,202GBP
€3425EUR$3,850USD£2,975GBP
- Report
- October 2025
- 200 Pages
Global
From €4403EUR$4,950USD£3,825GBP
- Report
- October 2025
- 110 Pages
Global
From €3069EUR$3,450USD£2,666GBP
- Report
- September 2025
- 140 Pages
Global
From €3667EUR$4,123USD£3,186GBP
€4314EUR$4,850USD£3,748GBP
- Report
- June 2025
- 191 Pages
Global
From €4403EUR$4,950USD£3,825GBP
- Report
- June 2025
- 208 Pages
Global
From €4403EUR$4,950USD£3,825GBP
- Report
- June 2025
- 102 Pages
Global
From €3069EUR$3,450USD£2,666GBP
- Report
- May 2025
- 150 Pages
Global
From €3667EUR$4,123USD£3,186GBP
€4314EUR$4,850USD£3,748GBP
- Report
- April 2025
- 223 Pages
Global
From €4443EUR$4,995USD£3,860GBP
- Report
- November 2024
- 130 Pages
United States
From €5293EUR$5,950USD£4,598GBP
- Report
- April 2025
- 84 Pages
United States
From €3113EUR$3,500USD£2,705GBP
- Report
- March 2025
- 120 Pages
North America
From €3558EUR$4,000USD£3,091GBP
- Report
- February 2025
- 133 Pages
Middle East
From €3558EUR$4,000USD£3,091GBP
- Report
- October 2025
- 76 Pages
Middle East, Africa
From €3069EUR$3,450USD£2,666GBP

Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age. It is characterized by a hormonal imbalance, which can lead to irregular menstrual cycles, infertility, and other physical and psychological symptoms. PCOS is also associated with an increased risk of developing type 2 diabetes, cardiovascular disease, and endometrial cancer.
PCOS is a major public health concern, as it affects an estimated 5-10% of women of reproductive age worldwide. Diagnosis and management of PCOS can be challenging due to its complex and varied symptoms. Treatment typically involves lifestyle modifications, such as diet and exercise, as well as medications to regulate hormones and reduce symptoms.
The PCOS market is a growing segment of the women's health industry, with a range of products and services available to diagnose and manage the condition. Companies in the PCOS market include pharmaceutical companies, medical device manufacturers, and digital health companies. Examples include AbbVie, Bayer, and Ovascience. Show Less Read more